Lipocine Inc. Profile Avatar - Palmy Investing

Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions …

Biotechnology
US, Salt Lake City [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Lipocine Inc. has no acquisition track records yet.

M&A Deals · History

Lipocine Inc. has no acquisition track records yet.

End of LPCN's Analysis
CIK: 1535955 CUSIP: 53630X104 ISIN: US53630X2036 LEI: - UEI: -
Secondary Listings
LPCN has no secondary listings inside our databases.